Alivus Life Sciences (formerly Glenmark Life Sciences) reported FY25 turnover of ₹23,869 Cr and net worth of ₹28,174 Cr, with strong exports comprising 51.7% of sales to over 75 countries.

The company is actively pursuing sustainability, significantly reducing its carbon footprint and improving water efficiency.

Key operational improvements include adopting Nano-filtration for solvent recovery.

A ₹15 Lakh fine for a past environmental violation was promptly resolved with no ongoing impact.

Alivus is boosting employee well-being and community development, recognized with an award for its social impact efforts.